Jane Street
BBIO icon

Jane Street’s BridgeBio Pharma BBIO Stock Holding History

Jane Street’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.83M Sell
78,500
-57,200
-42% -$4.15M ﹤0.01% 3283
2025
Q4 		$10.4M Sell
135,700
-43,700
-24% -$2.87M ﹤0.01% 2270
2025
Q3 		$9.32M Sell
179,400
-122,200
-41% -$5.96M ﹤0.01% 2511
2025
Q2 		$13M Buy
301,600
+66,800
+28% +$2.43M ﹤0.01% 1854
2025
Q1 		$8.12M Buy
234,800
+65,800
+39% +$2.22M ﹤0.01% 2262
2024
Q4 		$4.64M Buy
169,000
+68,300
+68% +$1.77M ﹤0.01% 2768
2024
Q3 		$2.56M Sell
100,700
-71,300
-41% -$1.87M ﹤0.01% 3990
2024
Q2 		$4.36M Sell
172,000
-38,700
-18% -$1.06M ﹤0.01% 3182
2024
Q1 		$6.51M Buy
210,700
+181,500
+622% +$6.17M ﹤0.01% 2270
2023
Q4 		$1.18M Sell
29,200
-89,100
-75% -$2.68M ﹤0.01% 5272
2023
Q3 		$3.12M Sell
118,300
-390,000
-77% -$11.1M ﹤0.01% 3314
2023
Q2 		$8.74M Buy
508,300
+232,800
+85% +$3.5M ﹤0.01% 2051
2023
Q1 		$4.57M Buy
275,500
+247,300
+877% +$2.88M ﹤0.01% 2583
2022
Q4 		$215K Sell
28,200
-27,800
-50% -$266K ﹤0.01% 7559
2022
Q3 		$557K Buy
56,000
+6,900
+14% +$71.7K ﹤0.01% 6489
2022
Q2 		$446K Sell
49,100
-47,200
-49% -$395K ﹤0.01% 6937
2022
Q1 		$977K Sell
96,300
-123,700
-56% -$1.27M ﹤0.01% 6186
2021
Q4 		$3.67M Buy
220,000
+207,100
+1,605% +$8.76M ﹤0.01% 3358
2021
Q3 		$605K Sell
12,900
-35,500
-73% -$1.9M ﹤0.01% 6914
2021
Q2 		$2.95M Buy
48,400
+30,100
+164% +$1.72M ﹤0.01% 3606
2021
Q1 		$1.13M Buy
18,300
+4,700
+35% +$307K ﹤0.01% 5228
2020
Q4 		$967K Buy
+13,600
New +$656K ﹤0.01% 4712

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's BBIO Position: Q1 2026 in Review

Jane Street increased its BridgeBio Pharma (BBIO) stake by 414% in Q1 2026, buying an estimated $103M and bringing the position to 1,757,672 shares worth $131M. The position accounts for 0.02% of the portfolio, ranked #532.

Jane Street first reported a position in BBIO in Q2 2020 and has held it in 24 quarters since. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Jane Street held 1,757,672 shares of BridgeBio Pharma worth $131M as of Q1 2026.
  • Jane Street bought 1,415,877 BridgeBio Pharma shares in Q1 2026, an estimated $103M.
  • BridgeBio Pharma made up 0.02% of Jane Street's portfolio in Q1 2026, its #532 holding.
  • Jane Street first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 24 quarters since.
  • 458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.